<DOC>
	<DOCNO>NCT01425060</DOCNO>
	<brief_summary>Nearly 9 every 10 pregnant opioid-dependent woman report current pregnancy unintended majority non-pregnant opioid-maintained woman use contraception use less effective method like condom . This proposal aim develop test novel contraceptive management program increase use effective contraceptive among opioid-maintained woman examine impact effective contraceptive use condom use . The propose research may reduce unintended pregnancy among opioid-dependent woman without increase risk sexually transmitted infection knowledge gain also implication address high rate unintended pregnancy general population .</brief_summary>
	<brief_title>Improving Effective Contraceptive Use Among Opioid-maintained Women</brief_title>
	<detailed_description>The rate unintended pregnancy among opioid-dependent woman extremely high : nearly 9 every 10 pregnant opioid-dependent woman report current pregnancy unintended , rate 2-3 time general population . Despite dire statistic , dearth scientific knowledge contraceptive use population promote use effective contraceptive ( e.g. , birth control pill , IUDs , implant ) . The aim Stage I Behavioral Integrative Treatment Development Program application develop pilot test novel contraceptive management program increase use effective contraceptive among OM woman . OM woman ( N=100 ) risk unintended pregnancy randomly assign 6-month contraceptive management program usual care . The contraceptive management program consist two component : ( 1 ) World Health Organization 's contraception protocol ( 2 ) reinforce follow-up visit . At first visit , participant assign contraceptive management program complete WHO 's contraception protocol , consist assistance choose contraceptive method , structure educational counseling choose method , free supply method , option initiate method immediately . Subsequently , contraceptive management program participant earn voucher-based incentive reinforce attendance follow-up visit receive support manage side effect problem-solve compliance problem , refill choose method , assistance switch method indicate . At visit , contraceptive management program participant also counsel risk sexually transmit infection ( STIs ) , include HIV/AIDS , need dual protection ( i.e. , protection pregnancy STIs ) , provide supply condom . Participants assign usual care condition give general information contraceptive option contact information clinic provider provide contraceptive service . Contraceptive use participant evaluate assessment schedule 1 , 3 , 6 month trial intake . The impact prescription contraceptive use condom use also assess . It hypothesize contraceptive management program increase effective contraceptive use without decrease condom use . The propose project seminal study intervention increase effective contraceptive use OM woman first step towards overarch goal develop efficacious , empirically base contraceptive management program disseminate drug treatment facility throughout country . The propose research also hold significant potential impact public health general , development efficacious program help reduce vast economic societal cost associate unintended pregnancy among drug-dependent non-drug-dependent woman alike .</detailed_description>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>1844 year age premenopausal history tubal ligation hysterectomy heterosexual vaginal sex past 12 month plan become pregnant next 6 month medically eligible use prescription contraceptive report prescription contraceptive method use ( i.e. , use pill , patch , ring past 7 day depot injection , implant , IUD past 3 month ) OR report primary use nonprescription method ( i.e. , condom , sponge , diaphragm , withdrawal , rhythm method ) opioid maintenance treatment least past 30 day Englishspeaking . failure meet aforementioned inclusion criterion refusal participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Unintended pregnancy</keyword>
	<keyword>HIV</keyword>
	<keyword>HIV Risk</keyword>
	<keyword>Sexually Transmitted Infections</keyword>
	<keyword>Women</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Neonatal Health</keyword>
	<keyword>Drug Use</keyword>
	<keyword>Drug Treatment</keyword>
	<keyword>Opioids</keyword>
</DOC>